Type 1 Diabetes Intervention Trials: What Have We Learned? A Critical Review of Selected Intervention Trials

2002 ◽  
Vol 104 (2) ◽  
pp. 97-104 ◽  
Author(s):  
Carla J. Greenbaum
2001 ◽  
Vol 2 (1) ◽  
pp. 2-11 ◽  
Author(s):  
Massimo Pietropaolo ◽  
Dorothy J Becker

2001 ◽  
Vol 2 (1) ◽  
pp. 2-11
Author(s):  
Massimo Pietropaolo ◽  
Dorothy J Becker

Diabetes Care ◽  
2004 ◽  
Vol 27 (4) ◽  
pp. 996-997 ◽  
Author(s):  
T. Wilkin ◽  
J. Ludvigsson ◽  
C. Greenbaum ◽  
J. Palmer ◽  
D. Becker ◽  
...  

2020 ◽  
Vol 105 (12) ◽  
pp. e4393-e4406 ◽  
Author(s):  
Mustafa Tosur ◽  
Mario A Cleves ◽  
Jay M Sosenko ◽  
Ingrid Libman ◽  
David A Baidal ◽  
...  

Abstract Objective We set forth to compare ethnicities for metabolic and immunological characteristics at the clinical diagnosis of type 1 diabetes (T1D) and assess the effect of ethnicity on beta-cell functional loss within 3 years after clinical diagnosis. Research Methods and Design We studied participants in TrialNet New Onset Intervention Trials (n = 624, median age = 14.4 years, 58% male, 8.7% Hispanic) and followed them prospectively for 3 years. Mixed meal tolerance tests (MMTT) were performed within 6 months following clinical diagnosis and repeated semiannually. Unless otherwise indicated, analyses were adjusted for age, sex, BMI Z-score, and diabetes duration. Results At T1D clinical diagnosis, Hispanics, compared with non-Hispanic whites (NHW), had a higher frequency of diabetic ketoacidosis (DKA) (44.7% vs 25.3%, OR = 2.36, P = 0.01), lower fasting glucose (97 vs 109 mg/dL, P = 0.02) and higher fasting C-peptide (1.23 vs 0.94 ng/mL, P = 0.02) on the first MMTT, and higher frequency of ZnT8 autoantibody positivity (n = 201, 94.1% vs 64%, OR = 7.98, P = 0.05). After exclusion of participants in experimental arms of positive clinical trials, C-peptide area under the curve (AUC) trajectories during the first 3 years after clinical diagnosis were not significantly different between Hispanics and NHW after adjusting for age, sex, BMI-z score, and DKA (n = 413, P = 0.14). Conclusion Despite differences in the metabolic and immunological characteristics at clinical diagnosis of T1D between Hispanics and NHW, C-peptide trajectories did not differ significantly in the first 3 years following clinical diagnosis after adjustment for body mass index and other confounders. These findings may inform the design of observational studies and intervention trials in T1D.


Diabetes ◽  
2003 ◽  
Vol 52 (5) ◽  
pp. 1059-1065 ◽  
Author(s):  
C. J. Greenbaum ◽  
L. C. Harrison

2011 ◽  
Vol 85 (2) ◽  
pp. 140-142 ◽  
Author(s):  
Shelagh A. Mulvaney ◽  
Russell L. Rothman ◽  
Chandra Y. Osborn ◽  
Cindy Lybarger ◽  
Mary S. Dietrich ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document